Gemeinschaftspraxis Haematologie und Onkologie

Dresden, Saxony-Anhalt 01307

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Pancreatic Adenocarcinoma

Studies at this site

• Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE) — Completed